FRANCE- BioMérieux has announced that its SPECIFIC REVEAL® Rapid Antimicrobial Susceptibility Test (AST) System has received the Breakthrough Device Designation from the U.S. Food and Drug Administration. This designation is…
Read MoreBioMérieux’s Antimicrobial Susceptibility Test System receives breakthrough device designation from U.S FDA
